Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation.

Authors:
Sagou K; Sato Y; Okuno Y; Watanabe T; Inagaki T and 5 more

Journal:
PLoS Pathog

Publication Year: 2024

DOI:
10.1371/journal.ppat.1011954

PMCID:
PMC10833513

PMID:
38300891

Journal Information

Full Title: PLoS Pathog

Abbreviation: PLoS Pathog

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Microbiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability all rna-seq datasets have been deposited to the dna data bank of japan (ddbj; https://www ddbj nig ac jp/index-e html ) under the accession number: dra016912.; data availability all rna-seq datasets have been deposited to the dna data bank of japan (ddbj; https://www ddbj nig ac jp/index-e html ) under the accession number: dra016912. file s1 table (xlsx"

Code Sharing
Evidence found in paper:

"H.Kiyoi has received research funding from FUJIFILM, Kyowa-Kirin, Bristol-Myers Squibb, Otsuka, Perseus Proteomics, Daiichi Sankyo, Abbvie, CURED, Astellas Pharma, Chugai, Zenyaku Kogyo, Nippon Shinyaku, Eisai, Takeda, Sumitomo Dainippon Pharma, and Sanofi, in addition to honoraria from Abbvie, Chugai, Astellas Pharma, and Novartis. Other authors declare no competing financial interests."

Evidence found in paper:

"This work was supported in part by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Numbers JP23K06559 to Y.S., JP23H02723 to H.Kimura., and JP22H02878 to Y.O.); the Japan Science and Technology Agency (JST) PRESTO (Grant Number JPMJPR19H5 to Y.S.), and CREST (Grant Number JPMJCR19H4 to Y.S. and S.T.); the Japan Agency for Medical Research and Development (AMED) (JP21wm0325042 to Y.S.); the Chemo-Sero-Therapeutic Research Institute to H.K.; the Aichi Health Promotion Foundation to K.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025